Data Sheet | Click for Datasheet |
---|---|
Catalog Number | PA06194 |
Size | 100μl |
Host Type | Rabbit |
Immunogen | Synthesized peptide derived from human ACK around the non-phosphorylation site of Y284. |
Specificity | The Tyr-284 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. It also shows a significant increase in expression in prostate cancers during the progressive stages. |
Isotype | IgG |
Reacitivity | Human,Mouse |
Clone | |
Uniprot | Q07912 |
Concentration | 1mg/mL |
Dilution | WB 1:500-1:2000, ELISA 1:10000 |
Formulation | Application | WB,IHC-p,ELISA |
Other Names | Acetate kinase 1,Acetokinase 1,ACK 1,ACK,ACK-1,ACK1,ACK1,Activated Cdc42 associated kinase 1,Activated CDC42 kinase 1,Activated p21cdc42Hs kinase,FLJ44758,FLJ45547,p21cdc42Hs,TNK 2,TNK2,Tyrosine kinase non receptor 2,Tyrosine kinase non receptor protein 2,Tyrosine kinase non-receptor protein 2 |
Storage | Lyophilized product: 5 years at 2 - 8°C; Solution: 2 years at -20°C. |
Postscript | For research use only, not for use in diagnostic procedures. |
© Copyright 2024 TZYBIOTECH. All Rights Reserved. SiteMap